7:01 AM ET
8-K
Leadership Change
Bruker Leadership Change
Bruker Corporation has appointed Dr. Eicke Latz to its Board of Directors, effective January 1, 2027, expanding the board to twelve members. Dr. Latz is a physician-scientist and biopharma entrepreneur who currently serves as the Scientific Director of the German Rheumatology Research Center. Additionally, the Board declared a quarterly cash dividend of $0.05 per share payable on January 7, 2027.